Trial · NCT01287520
Adverse events1,386
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,386
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | LY 10/Carb 5/Pem 500 (Cohort 1) | 2 | 3 | 3 |
| other | Anaemia | Blood and lymphatic system disorders | LY 10/Carb 6/Pem 500 (Cohort 2) | 6 | 7 | 8 |
| other | Anaemia | Blood and lymphatic system disorders | LY 20/Carb 6/Pem 500 (Cohort 3) | 5 | 5 | 5 |
| other | Anaemia | Blood and lymphatic system disorders | LY 40/Carb 6/Pem 500 (Cohort 4) | 5 | 7 | 5 |
| other | Anaemia | Blood and lymphatic system disorders | LY 80/Carb 6/Pem 500 (Cohort 5) | 2 | 3 | 3 |
| other | Anaemia | Blood and lymphatic system disorders | LY 120/Carb 6/Pem 500 (Cohort 6) | 0 | 4 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | LY 80/Carb 6/Pem 500 + R50 (Cohort 7) | 1 | 2 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | LY 60/Carb 6/Pem 500 + R50 (Cohort 8) | 4 | 5 | 4 |
| other | Anaemia | Blood and lymphatic system disorders | LY 40/Carb 6/Pem 500 + R50 (Cohort 9) | 3 | 5 | 5 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 10/Carb 5/Pem 500 (Cohort 1) | 0 | 3 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 10/Carb 6/Pem 500 (Cohort 2) | 0 | 7 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 20/Carb 6/Pem 500 (Cohort 3) | 0 | 5 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 40/Carb 6/Pem 500 (Cohort 4) | 0 | 7 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 80/Carb 6/Pem 500 (Cohort 5) | 0 | 3 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 120/Carb 6/Pem 500 (Cohort 6) | 0 | 4 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 80/Carb 6/Pem 500 + R50 (Cohort 7) | 1 | 2 | 1 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 60/Carb 6/Pem 500 + R50 (Cohort 8) | 0 | 5 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | LY 40/Carb 6/Pem 500 + R50 (Cohort 9) | 0 | 5 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | LY 10/Carb 5/Pem 500 (Cohort 1) | 0 | 3 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | LY 10/Carb 6/Pem 500 (Cohort 2) | 4 | 7 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01287520/events